Why Is ImmunityBio (IBRX) Rallying Today? EU Approves Anktiva
ImmunityBio stock surged more than 20% after the European Commission granted conditional approval for its bladder cancer treatment, Anktiva.
Telegram News Wire
Danaher (DHR) Stock Slides on $10B Masimo Buyout Announcement
Danaher stock fell after the company announced a $9.9B all-cash deal to buy Masimo, expanding its diagnostics and patient monitoring business.